T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.81B |
| 2 |
Boeing
BA
|
+$1.68B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.33B |
| 4 |
Amphenol
APH
|
+$1.11B |
| 5 |
CME Group
CME
|
+$902M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.65B |
| 2 |
Advanced Micro Devices
AMD
|
+$2.51B |
| 3 |
UnitedHealth
UNH
|
+$2.06B |
| 4 |
Uber
UBER
|
+$1.84B |
| 5 |
Adobe
ADBE
|
+$1.44B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.21% |
| 2 | Healthcare | 12.77% |
| 3 | Consumer Discretionary | 11.71% |
| 4 | Financials | 11.15% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DESP
2301
DELISTED
Despegar.com
DESP
| $467K | ﹤0.01% |
24,210
+3,856
| +19% | +$60.7K |
|
|
VTLE
2302
DELISTED
Vital Energy
VTLE
| $465K | ﹤0.01% |
15,014
+1,732
| +13% | +$51.3K |
|
2303
Reynolds Consumer Products
REYN
$5.55B
| $464K | ﹤0.01% |
17,168
+2,837
| +20% | +$80.5K |
|
|
GOOD
2304
Gladstone Commercial Corp
GOOD
$641M
| $463K | ﹤0.01% |
28,450
+3,210
| +13% | +$53.2K |
|
2305
Arcus Biosciences
RCUS
$3.67B
| $461K | ﹤0.01% |
30,948
-6,265
| -17% | -$102K |
|
|
KLG
2306
DELISTED
WK Kellogg Co
KLG
| $459K | ﹤0.01% |
25,474
+3,945
| +18% | +$72.2K |
|
2307
Intellia Therapeutics
NTLA
$1.66B
| $459K | ﹤0.01% |
39,295
-543,237
| -93% | -$8.48M |
|
2308
American Express Global Business Travel
GBTG
$4.94B
| $458K | ﹤0.01% |
49,353
+8,214
| +20% | +$70.1K |
|
2309
Mesa Laboratories
MLAB
$633M
| $458K | ﹤0.01% |
3,469
+390
| +13% | +$47.9K |
|
2310
BP
BP
$110B
| $457K | ﹤0.01% |
15,421
-3,377,262
| -100% | -$101M |
|
2311
PagSeguro Digital
PAGS
$2.43B
| $457K | ﹤0.01% |
72,915
+4,662
| +7% | +$35.8K |
|
2312
Scholastic
SCHL
$784M
| $457K | ﹤0.01% |
21,409
-23,175
| -52% | -$588K |
|
2313
Malibu Boats
MBUU
$573M
| $456K | ﹤0.01% |
12,111
+1,103
| +10% | +$45.7K |
|
2314
N-able
NABL
$695M
| $456K | ﹤0.01% |
48,764
+4,821
| +11% | +$54K |
|
|
ZEUS
2315
DELISTED
Olympic Steel
ZEUS
| $456K | ﹤0.01% |
13,891
+839
| +6% | +$32.5K |
|
|
CDMO
2316
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $454K | ﹤0.01% |
36,753
+3,427
| +10% | +$39.3K |
|
2317
Dine Brands
DIN
$440M
| $453K | ﹤0.01% |
15,046
+871
| +6% | +$28K |
|
2318
Sable Offshore Corp
SOC
$773M
| $450K | ﹤0.01% |
19,613
+3,001
| +18% | +$65.7K |
|
2319
Winmark
WINA
$1.26B
| $449K | ﹤0.01% |
1,141
+180
| +19% | +$70.7K |
|
2320
MiMedx Group
MDXG
$612M
| $447K | ﹤0.01% |
46,446
+7,189
| +18% | +$56K |
|
2321
SI-BONE Inc
SIBN
$849M
| $446K | ﹤0.01% |
31,742
+3,318
| +12% | +$44.6K |
|
2322
U-Haul Holding Co
UHAL
$14.4B
| $443K | ﹤0.01% |
6,408
+386
| +6% | +$28K |
|
2323
Health Catalyst
HCAT
$132M
| $442K | ﹤0.01% |
62,443
+4,798
| +8% | +$38.2K |
|
2324
Invesco Mortgage Capital
IVR
$805M
| $442K | ﹤0.01% |
54,831
+6,271
| +13% | +$52.6K |
|
2325
Kodak
KODK
$978M
| $442K | ﹤0.01% |
67,170
+3,449
| +5% | +$19.6K |
|
Similar funds
T. Rowe Price Associates's Q4 2024 Portfolio in Review
As of Q4 2024, T. Rowe Price Associates held 3,110 positions worth $867B, down 0.13% from $869B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
T. Rowe Price Associates's Q4 2024 filing shows 92 new, 1,805 increased, 946 reduced and 96 closed positions. Its largest new stake was South Bow Corp: 12,337,055 shares worth $291M. The largest sale was Apple, an estimated $3.65B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2024 buy was South Bow Corp: 12,337,055 shares worth $291M.
- T. Rowe Price Associates added most to Broadcom in Q4 2024, an estimated $2.81B increase.
- T. Rowe Price Associates's biggest Q4 2024 reduction was Apple, cutting an estimated $3.65B.
- T. Rowe Price Associates fully exited Tempus AI in Q4 2024, selling an estimated $292M.
- T. Rowe Price Associates's ten largest holdings make up 35% of its $867B portfolio in Q4 2024.
- T. Rowe Price Associates opened 92 new positions and closed 96 in Q4 2024.
- T. Rowe Price Associates's portfolio value fell 0.13% quarter-over-quarter to $867B.
Based on T. Rowe Price Associates's 13F filing for Q4 2024, filed 14 Feb 2025.